Search Filters

Search Results

Found 6 results

510(k) Data Aggregation

    K Number
    K250578
    Date Cleared
    2025-04-01

    (33 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Nitrile Examination Gloves Powder Free Tested for Use With Chemotherapy Drugs & Fentanyl Citrate (Blue

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner. These gloves were tested for use with Chemotherapy Drugs and Fentanyl Citrate as per ASTM D6978-05 (Reapproved 2019) Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs.

    Device Description

    Non-Sterile Nitrile Patient Examination Glove is made from synthetic rubber latex. It is single use and powder-free class I Nitrile Patient Examination Gloves which coated by on-line polymer with mild on-line chlorination process. These processes modify the surface characteristics and causes it to remain tack-free without the use of any dusting or donning powder. The available sizes are X-Small, Small, Medium, Large and X-Large. The Nitrile Examination Gloves Powder Free (Blue & Black) have been tested for Chemotherapy Drugs. The subject devices are identical in design and formulation to the predicate gloves of K230121.

    AI/ML Overview

    The provided FDA 510(k) clearance letter pertains to Nitrile Examination Gloves Powder Free Tested for Use With Chemotherapy Drugs & Fentanyl Citrate (Blue & Black), a medical device. This type of device is classified as a Class I medical device and does not involve AI/ML technology. Therefore, many of the requested categories related to AI/ML device studies (e.g., sample sizes for test/training sets, ground truth establishment, MRMC studies, standalone performance, expert qualifications, adjudication methods, effect sizes) are not applicable.

    The acceptance criteria and device performance are primarily evaluated based on material properties, chemical permeation resistance, and biocompatibility, using established ASTM and ISO standards for examination gloves.

    1. Table of Acceptance Criteria and Reported Device Performance

    The device, "NITRILE EXAMINATION GLOVES POWDER FREE TESTED FOR USE WITH CHEMOTHERAPY DRUGS & FENTANYL CITRATE (BLUE & BLACK)", was tested against various physical, chemical, and biological criteria.

    Test CategoryCharacteristic / StandardAcceptance CriteriaReported Device Performance (Result)
    PreambleProduct CodeLZA, LZC, QDO, OPJLZA, LZC, QDO, OPJ
    Intended UseTo prevent contamination between patient and examinerMeets stated intended use
    DesignPowder Free, Non-Sterile, Ambidextrous, Beaded CuffPowder Free, Non-Sterile, Ambidextrous, Beaded Cuff
    ConstructionAmbidextrous, Polymer Coated or Chlorinated, Powder Free NitrileAmbidextrous, Polymer Coated or Chlorinated, Powder Free Nitrile
    Color DescriptionBlue & BlackBlue & Black
    MaterialNitrileNitrile
    Single UseYesYes
    PackagingPacked in Dispenser BoxesPacked in Dispenser Boxes
    SterilityNon-SterileNon-Sterile
    Freedom From HolesASTM D6319-19, ASTM D5151-19Meet requirement inspection level G-1, AQL 2.5Pass
    DimensionASTM D6319-19Length (XS), min. 220mmMeet 220mm min
    Length (S, M, L, XL), min. 230mmMeet 230mm min
    Thickness (palm/finger), min. 0.05mmMeet 0.05mm min
    Width (XS), 70 ± 10 mmMeet 70 ± 10 mm
    Width (S), 80 ± 10 mmMeet 80 ± 10 mm
    Width (M), 95 ± 10 mmMeet 95 ± 10 mm
    Width (L), 110 ± 10 mmMeet 110 ± 10 mm
    Width (XL), 120 ± 10 mmMeet 120 ± 10 mm
    Physical Properties (Before Ageing)ASTM D6319-19Tensile Strength, 14 MPa min.Meet 14MPa min.
    Ultimate Elongation, 500% min.Meet 500% min.
    Physical Properties (After Accelerated Aging)ASTM D6319-19Tensile Strength, 14 MPa min.Meet 14MPa min.
    Ultimate Elongation, 400% min.Meet 400% min.
    Residual Powder ContentASTM D6319-19, ASTM D6124-06Not more than 2 mg per gloveMeet 2mg/glove max.
    Biocompatibility - Primary Skin IrritationISO 10993-10Not a primary skin irritantPass (did not cause an irritant response)
    Biocompatibility - Skin SensitizationISO 10993-10Not a contact sensitizerPass (did not produce a skin sensitization effect)
    Biocompatibility - In Vitro CytotoxicityISO 10993-5:2009No adverse biological reactionModerate cytotoxicity reactivity at 6.0 cm²/mL extract concentrations and no cytotoxicity reactivity at 3.0 cm²/mL extract concentrations.
    Biocompatibility - Acute Systemic ToxicityISO 10993-11No adverse biological reactionPass (no adverse biological reaction)
    Chemotherapy Drug PermeationASTM D6978-05 (Reapproved 2019)Varies by drug (Breakthrough Detection Time)See detailed table below

    Detailed Chemotherapy Drug and Fentanyl Citrate Permeation Performance:

    Chemotherapy Drugs and Fentanyl CitrateConcentrationMinimum Breakthrough Detection Time (minutes) - Blue GloveMinimum Breakthrough Detection Time (minutes) - Black Glove
    *Carmustine (BCNU)3.3 mg/ml22.621.8
    Cisplatin1.0 mg/ml>240 min>240 min
    Cyclophosphamide (Cytoxan)20.0 mg/ml>240 min>240 min
    Dacarbazine10.0 mg/ml>240 min>240 min
    Doxorubicin HCL2.0 mg/ml>240 min>240 min
    Etoposide20.0 mg/ml>240 min>240 min
    Fluorouracil50.0 mg/ml>240 min>240 min
    Ifosfamide50.0 mg/ml>240 min>240 min
    Mitoxantrone2 mg/ml>240 min>240 min
    Paclitaxel6.0 mg/ml>240 min>240 min
    *Thio Tepa10.0 mg/ml43.917.7
    Vincristine Sulfate1.0 mg/ml>240 min>240 min
    Methotrexate25.0 mg/ml>240 min>240 min
    Mitomycin C.0.5 mg/ml>240 min>240 min
    Fentanyl Citrate100mcg/2ml>240 min>240 min
    *Warning: Do not use with Carmustine and Thiotepa due to extremely low permeation times.

    2. Sample Size Used for the Test Set and Data Provenance

    The document does not explicitly state the exact sample sizes for each test (e.g., number of gloves tested for permeation, holes, dimensions, etc.) but refers to adherence to the methodologies outlined in the specified ASTM and ISO standards. These standards typically define minimum sample sizes for material testing.

    • Data Provenance: The document states the applicant is from Malaysia (Careglove Global Sdn. Bhd.). The testing was conducted according to international standards (ASTM, ISO), implying the tests were performed in a controlled laboratory environment, likely by the manufacturer or a contracted lab. The data is non-clinical and derived from prospective testing of manufactured glove samples.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    Not applicable. This device is not an AI/ML device that requires expert review for "ground truth" establishment in the context of diagnostic or interpretive tasks. The "ground truth" for material properties is established by the physical and chemical measurements themselves, according to standardized protocols and certified laboratory equipment.

    4. Adjudication Method for the Test Set

    Not applicable. This device is not an AI/ML device that requires adjudication for interpretations. Test results are objective measurements against predefined criteria.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done

    Not applicable. MRMC studies are relevant for diagnostic or interpretive AI/ML devices where human readers' performance is evaluated with and without AI assistance. This is a physical and chemical barrier device.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Study Was Done

    Not applicable. This device is a passive physical barrier and does not involve any algorithms or software.

    7. The Type of Ground Truth Used

    The "ground truth" for this device is based on objective measurements of physical properties (e.g., length, thickness, tensile strength, elongation), chemical resistance (breakthrough detection time), and biological reactivity (biocompatibility tests), as defined by internationally recognized standards (ASTM, ISO). There is no subjective human "ground truth" in this context.

    8. The Sample Size for the Training Set

    Not applicable. This is not an AI/ML device that undergoes "training."

    9. How the Ground Truth for the Training Set Was Established

    Not applicable. This is not an AI/ML device. The manufacturing process of the gloves is designed to meet the specified standards, and quality control ensures consistency, but this is not "training" in the context of AI/ML.

    Ask a Question

    Ask a specific question about this device

    K Number
    K233042
    Date Cleared
    2023-12-06

    (72 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Device Name :

    Sterile Nitrile Examination Gloves Powder Free Tested for Use with Chemotherapy Drugs and Fentanyl Citrate

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use
    Device Description
    AI/ML Overview
    Ask a Question

    Ask a specific question about this device

    K Number
    K230121
    Date Cleared
    2023-05-15

    (118 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Nitrile Examination Gloves Powder Free Tested For Use With Chemotherapy Drugs & Fentanyl Citrate (Blue

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner.

    These gloves were tested for use with Chemotherapy Drugs and Fentanyl Citrate per ASTM D6978-05 (Reapproved 2019) Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs.

    Device Description

    Non-Sterile Nitrile Patient Examination Glove is made from synthetic rubber latex. It is single use and powderfree variation of the class I Nitrile Patient Examination Gloves which is coated by on-line polymer with mild on-line chlorination process. These processes modify the surface characteristics and causes it to remain tack-free without the use of any dusting or donning powder. The available sizes are X-Small, Medium, Large and X-Large. The Nitrile Examination Gloves Powder Free (Blue & Black) have been tested for Chemotherapy Drugs and Fentanyl Citrate.

    AI/ML Overview

    This document describes the testing for Nitrile Examination Gloves, focusing on their resistance to chemotherapy drugs and Fentanyl Citrate. The study assesses the gloves' physical properties, biocompatibility, and chemical permeation alongside the reported device performance.


    1. Table of Acceptance Criteria and Reported Device Performance

    Chemotherapy and Fentanyl Citrate Permeation (Minimum Breakthrough Detection Time)

    Chemotherapy DrugsConcentrationAcceptance Criteria (from ASTM D6978-05 implied by claim of use)Reported Device Performance (Blue Glove)Reported Device Performance (Black Glove)
    Carmustine (BCNU)3.3 mg/mlNo specific public acceptance criterion provided but tested22.6 minutes21.8 minutes
    Cisplatin1.0 mg/mlNo specific public acceptance criterion provided but tested>240 minutes>240 minutes
    Cyclophosphamide (Cytoxan)20.0 mg/mlNo specific public acceptance criterion provided but tested>240 minutes>240 minutes
    Dacarbazine10.0 mg/mlNo specific public acceptance criterion provided but tested>240 minutes>240 minutes
    Doxorubicin HCl2.0 mg/mlNo specific public acceptance criterion provided but tested>240 minutes>240 minutes
    Etoposide20.0 mg/mlNo specific public acceptance criterion provided but tested>240 minutes>240 minutes
    Fluorouracil50.0 mg/mlNo specific public acceptance criterion provided but tested>240 minutes>240 minutes
    Ifosfamide50.0 mg/mlNo specific public acceptance criterion provided but tested>240 minutes>240 minutes
    Mitoxantrone2 mg/mlNo specific public acceptance criterion provided but tested>240 minutes>240 minutes
    Paclitaxel6.0 mg/mlNo specific public acceptance criterion provided but tested>240 minutes>240 minutes
    Thiotepa10.0 mg/mlNo specific public acceptance criterion provided but tested43.9 minutes17.7 minutes
    Vincristine Sulfate1.0 mg/mlNo specific public acceptance criterion provided but tested>240 minutes>240 minutes
    Fentanyl Citrate Injection100mcg/2mlNo specific public acceptance criterion provided but tested>240 minutes>240 minutes
    WarningAdvised against use if permeation time is too lowCarmustine, Thiotepa warningCarmustine, Thiotepa warning

    Physical Properties, Dimensional, and Biocompatibility Testing

    TestMethodAcceptance CriteriaReported Device Performance
    Freedom From HolesASTM D6319-19, D5151-19Requirement inspection level G-1, AQL 2.5Pass
    Dimension (Length, Thickness, Width)ASTM D6319-19Length: min. 220mm, 230mm. Thickness: min. 0.05mm. Width: 70-120mm (based on size)Pass (Meets requirements for various sizes)
    Physical Properties (Before Aging)ASTM D6319-19Tensile Strength: 14 MPa min. Ultimate Elongation: 500% min.Pass (Meets 14MPa min, 500% min)
    Physical Properties (After Aging)ASTM D6319-19Tensile Strength: 14 MPa min. Ultimate Elongation: 400% min.Pass (Meets 14MPa min, 400% min)
    Residual Powder ContentASTM D6319-19, D6124-06Not more than 2 mg per glovePass
    Primary Skin Irritation TestISO 10993-10Not a primary skin irritantPass (Did not cause an irritant response)
    Skin Sensitization TestISO 10993-10Not a contact sensitizerPass (Did not produce a skin sensitization effect)
    In Vitro Cytotoxicity TestISO 10993-5:2009No adverse biological reactionModerate cytotoxicity at 6.0 cm²/mL; No reactivity at 3.0 cm²/mL
    Acute Systemic ToxicityISO 10993-11No adverse biological reactionPass (No adverse biological reaction)

    2. Sample Size Used for the Test Set and Data Provenance

    The document does not explicitly state the sample size (number of gloves) used for the permeation, physical property, or biocompatibility tests.
    The data provenance is not explicitly mentioned (e.g., country of origin, retrospective or prospective). However, the tests were conducted according to international standards (e.g., ASTM, ISO), which implies a standardized, prospective testing approach in a laboratory setting. The applicant is based in Malaysia.


    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    Not applicable. This is not a study involving expert readers or ground truth established by medical professionals. The "ground truth" for this device is determined by objective, standardized laboratory measurements (e.g., chemical permeation time, physical properties, biological reactions) as defined by the referenced ASTM and ISO standards.


    4. Adjudication Method for the Test Set

    Not applicable. There was no human adjudication process involved as the "ground truth" is determined by objective laboratory measurements and adherence to specified test standards.


    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was Done

    No, an MRMC comparative effectiveness study was not done. This type of study is relevant for diagnostic devices that involve human interpretation of medical images or data. The device in question is examination gloves, and its performance is evaluated through physical, chemical, and biological testing, not by human readers interpreting cases.


    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was Done

    Not applicable. This is a medical device (examination gloves), not an AI algorithm. Therefore, the concept of "standalone" performance for an algorithm does not apply. All listed tests are "standalone" in the sense that they assess the intrinsic properties of the glove without human intervention in the measurement process itself, though human technicians conduct and analyze the tests.


    7. The Type of Ground Truth Used

    The ground truth used for this study is based on:

    • Performance Standards: Defined by international standards such as ASTM D6978-05 (for chemotherapy drug permeation), ASTM D6319-19, ASTM D5151-19, ASTM D6124-06 (for physical properties and hole freedom), and ISO 10993-10, ISO 10993-5:2009, ISO 10993-11 (for biocompatibility).
    • Objective Laboratory Measurements: Direct measurements of breakthrough time, dimensional properties, tensile strength, elongation, residual powder, and biological response to the glove materials.

    8. The Sample Size for the Training Set

    Not applicable. There is no training set mentioned or implied in this submission, as the device is not an AI/ML algorithm that requires training data.


    9. How the Ground Truth for the Training Set was Established

    Not applicable, as there is no training set for this device.

    Ask a Question

    Ask a specific question about this device

    Why did this record match?
    Device Name :

    Jr Medic Blue Nitrile Examination Gloves Powder Free tested for use with Chemotherapy drugs and Fentanyl

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Jr Medic Blue Nitrile Examination Gloves Powder Free tested for use with Chemotherapy drugs and Fentanyl Citrate is a disposable device intended for medical purpose that is worn on the examiner's hand to prevent contamination between patient and examiner. Additionally, the gloves were tested for use with chemotherapy drugs and Fentanyl Citrate in accordance with ASTM D6978-05 (2019) Standard Practice for Assessment of Medical Glove to Permeation by Chemotherapy Drugs.

    Device Description

    The subject device in 510(K) notification is a blue nitrile examination gloves powder free tested for use with Chemotherapy drugs and Fentanyl Citrate. The subject device is a patient examination glove made from acrylonitrile-butadiene copolymer dispersion, blue color, powder free and non sterile (as per 21CFR 880.6250, class I). The device is available in Small, Medium, Large and Extra Large sizes. The subject device meets all the current specifications listed under the ASTM Specification D 6319 -2019, Standard Specification for Nitrile Examination Gloves for Medical Application. This device also complies with requirements for standard practice for assessment of resistance of medical gloves to permeation by chemotherapy drugs as per ASTM D6978- 05(2019)

    AI/ML Overview

    The provided document is a 510(k) premarket notification for "Jr Medic Blue Nitrile Examination Gloves Powder Free tested for use with Chemotherapy drugs and Fentanyl Citrate." This document outlines the acceptance criteria and the results of a study to demonstrate the device's performance.

    Here's the breakdown of the information requested based on the provided text:

    1. A table of acceptance criteria and the reported device performance

    The document provides extensive tables for the performance of the gloves. Rather than recreating the entire tables found on pages 10-14, a summary of key acceptance criteria and reported performance is presented below. Please refer to pages 10-14 of the original document for the complete lists of chemotherapy drugs and specific results.

    Test Method (Standard)PurposeAcceptance CriteriaReported Device Performance
    ASTM D6319-2019Length of the glovesMin 220 mm for Size Small & Min 230 mm for all other sizesSmall: 404 mm
    Medium: 405 mm
    Large: 405 mm
    X-Large: 406 mm (All exceed minimums)
    ASTM D6319-2019Width of the glovesSmall: 80+/-10 mm; Medium: 95+/-10 mm; Large: 110+/-10 mm; X-Large: 120+/-10 mmSmall: 84 mm
    Medium: 94 mm
    Large: 105 mm
    X-Large: 115 mm (All within +/- 10mm range)
    ASTM D6319-2019Thickness of the glovesPalm 0.05 mm min; Finger 0.05 mm min for all sizesPalm: 0.19mm (all sizes); Finger: 0.21mm (all sizes) (All exceed minimums)
    ASTM D6319-2019Physical properties - Tensile strength (Before Ageing)$\ge$ 14 Mpa for all sizesSmall: 22.77Mpa; Medium: 24.46Mpa; Large: 24.51Mpa; X-Large: 24.59Mpa (All exceed minimum)
    ASTM D6319-2019Physical properties - Tensile strength (After Ageing)$\ge$ 14 Mpa for all sizesSmall: 20.50Mpa; Medium: 21.81Mpa; Large: 21.95Mpa; X-Large: 22.05Mpa (All exceed minimum)
    ASTM D6319-2019Physical properties - Ultimate Elongation (Before Ageing)$\ge$ 500% for all sizesSmall: 885%; Medium: 888%; Large: 891%; X-Large: 892% (All exceed minimum)
    ASTM D6319-2019Physical properties - Ultimate Elongation (After Ageing)$\ge$ 400% for all sizesSmall: 868%; Medium: 870%; Large: 872%; X-Large: 875% (All exceed minimum)
    ASTM D5151-2019Detection of Holes in Medical GlovesAQL 2.5Passes AQL 1.5 (Better than acceptance criteria, indicating fewer defects)
    ASTM D6124-06Residual Powder on Medical Gloves2 Mg/Glove MaxSmall: 0.16 mg/glove; Medium: 0.16 mg/glove; Large: 0.16 mg/glove; X-Large: 0.16mg/glove (All meet or are below maximum)
    ASTM D6978-05 (2019)Permeation by Chemotherapy Drugs and Fentanyl CitrateSpecified minimum breakthrough detection times for each drug (e.g., >240 Minutes for most)Most chemotherapy drugs and Fentanyl Citrate showed >240 Minutes breakthrough detection time.
    Exceptions: Carmustine (3.3 mg/ml) - 35.0 Minutes; Thiotepa (10 mg/ml) - 64.9 Minutes. Warnings are provided for these two drugs. (See pages 2-3 and 12-13 for full list and values).
    ISO 10993-10Dermal Irritation (Rabbits)Non irritantUnder the condition of study not an irritant (Meets criteria)
    ISO 10993-10Skin Sensitization (Guinea Pig)Non sensitizerUnder the conditions of the study not a sensitizer (Meets criteria)
    ISO 10993-5:2009In vitro CytotoxicityNon cytotoxicUnder the conditions of the study cytotoxic. (Does NOT meet criteria for non-cytotoxic)
    ISO 10993-11:2017Acute Systemic ToxicityNot pose systemic toxicity concernUnder the conditions of study the device extracts do not pose acute systemic toxicity concern (Meets criteria)
    ISO 10993-11:2017 / USP 41Material-Mediated PyrogenicityNot pose material mediated pyrogenicity responseUnder the conditions of the study, the device did not demonstrate a material mediated pyrogenicity response (Meets criteria)

    Note on Cytotoxicity: The device itself is reported as cytotoxic under the tested conditions. This is a critical finding that does not meet a "Non cytotoxic" acceptance criterion. However, the FDA has still cleared the device. This implies that either the level of cytotoxicity observed is deemed acceptable for the intended use and risk-benefit profile of examination gloves, or mitigating factors/information were provided elsewhere (not in this summary). It's important to note this discrepancy.

    2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    The document lists various ASTM and ISO standards for testing, which define the sample sizes required for each test (e.g., AQL levels for watertightness). However, the specific quantity/sample size used for each individual test conducted by the manufacturer is not explicitly stated in this summary document beyond what's implied by the standard (e.g., AQL 1.5 for watertightness performance is a characteristic, not a sample size).

    • Data Provenance: The manufacturing location of the device owner, JR Engineering & Medical Technologies (M) Sdn. Bhd., is in Malaysia (Lot 8 &10, Jalan Zurah 3 & Lot 1&3, Jalan Zurah 3A/1, Pusat Perindustrian 2, 44200 Rasa, Hulu Selangor, Selangor Darul Ehsan, Malaysia). The testing was conducted in accordance with international standards (ASTM, ISO), implying that the data originates from laboratory studies, likely conducted by third-party labs or the manufacturer's own qualified labs, but the specific country of the testing labs is not mentioned.
    • Retrospective or Prospective: The testing described is prospective laboratory performance testing of the device, rather than a retrospective analysis of existing data.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

    This product is a medical glove, not an AI or imaging device requiring expert consensus for ground truth. The "ground truth" for this device's performance is established through objective, standardized laboratory testing (e.g., ASTM D6319 for physical properties, ASTM D6978 for chemical permeation, ISO 10993 for biocompatibility). These tests rely on chemical and physical measurements, not human expert interpretation of images or clinical outcomes. Therefore, the concept of "number of experts used to establish ground truth" with qualifications like "radiologist with 10 years of experience" is not applicable to this type of device. The "experts" are the technicians and scientists performing the standardized validation tests.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    Not applicable. As this is not a study involving human interpretation of data where adjudication would be necessary (like in imaging diagnosis), there is no adjudication method described.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    Not applicable. This device is a physical examination glove, not an AI or imaging diagnostic tool that would involve human readers or AI assistance.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    Not applicable. This is not an algorithm or AI device. The tests performed are "standalone" in the sense that they assess the intrinsic material properties and barrier performance of the glove itself.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    The ground truth for this device is based on standardized, objective physical, chemical, and biological measurements obtained through laboratory testing, as defined by relevant ASTM and ISO standards. This includes:

    • Physical measurements (e.g., length, width, thickness, tensile strength, elongation).
    • Chemical analysis (e.g., residual powder, breakthrough detection time for drugs).
    • Biological testing (e.g., irritation, sensitization, cytotoxicity, systemic toxicity, pyrogenicity).

    8. The sample size for the training set

    Not applicable. This device is a manufactured product (glove), not an AI algorithm or model that requires a "training set" of data.

    9. How the ground truth for the training set was established

    Not applicable, as there is no training set for this device.

    Ask a Question

    Ask a specific question about this device

    K Number
    K223235
    Date Cleared
    2022-10-26

    (13 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Nitrile Examination Gloves Powder Free (Tested for use with Chemotherapy Drugs)

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Nitrile Examination Gloves Powder Free (Tested for use with Chemotherapy Drugs) is a disposable device intended for medical purpose that is worn on the examiner's hand to prevent contamination between patient and examiner. In addition, these gloves were tested for use with chemotherapy drugs in accordance with ASTM D6978-05 (2019) Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy Drugs. This is a single-use, powder-free, non-sterile device.

    Device Description

    Nitrile Examination Gloves Powder Free (Tested for use with Chemotherapy Drugs) is a Class I patient examination gloves bearing the product codes LZA, LZC, OPJ (21CFR880.6250). They meet all the current specifications listed under the ASTM D6319-19, Standard Specification for Nitrile Examination Gloves for Medical Application and also complies with requirements for Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy Drugs as per ASTM D6978-05 (2019). They are made from Carboxylated Nitrile. These gloves are blue in color and are powder free. The product is non-sterile, textured, ambidextrous with beaded cuff and single use only. Nitrile Examination Gloves Powder Free (Tested for use with Chemotherapy Drugs) with sizes X-Small, Small, Medium, Large, X-Large and XX-Large are included in the submission.

    AI/ML Overview

    Here's an analysis of the acceptance criteria and the study that proves the device meets them, based on the provided FDA 510(k) summary for "Nitrile Examination Gloves Powder Free (Tested for use with Chemotherapy Drugs)":

    1. A table of acceptance criteria and the reported device performance

    Characteristic / Test MethodAcceptance CriteriaReported Device Performance
    Physical Dimensions (ASTM D6319-19)
    LengthX-Small: 220 mm min; Small: 220 mm min; Medium: 230 mm min; Large: 230 mm min; X-Large: 230 mm min; XX-Large: 230 mm minX-Small: 270 mm; Small: 273 mm; Medium: 274 mm; Large: 276 mm; X-Large: 278 mm; XX-Large: 276 mm
    WidthX-Small: 70+/-10 mm; Small: 80+/-10 mm; Medium: 95+/-10 mm; Large: 110+/-10 mm; X-Large: 120+/-10 mm; XX-Large: 130+/-10 mmX-Small: 72 mm; Small: 82 mm; Medium: 97 mm; Large: 103 mm; X-Large: 112 mm; XX-Large: 126 mm
    ThicknessPalm: 0.05 mm min for all sizes; Finger: 0.05 mm min for all sizesPalm: 0.12 mm for all sizes; Finger: 0.14 mm for all sizes
    Physical Properties (ASTM D6319-19)
    Tensile Strength (Before Ageing)14 MPa min for all sizesX-Small: 17.7 MPa; Small: 18.1 MPa; Medium: 18.3 MPa; Large: 18.4 MPa; X-Large: 18.2 MPa; XX-Large: 18.5 MPa
    Tensile Strength (After Ageing)14 MPa min for all sizesX-Small: 16.8 MPa; Small: 17.3 MPa; Medium: 17.2 MPa; Large: 17.6 MPa; X-Large: 17.5 MPa; XX-Large: 17.6 MPa
    Ultimate Elongation (Before Ageing)500% min for all sizesX-Small: 637%; Small: 634%; Medium: 647%; Large: 630%; X-Large: 644%; XX-Large: 644%
    Ultimate Elongation (After Ageing)400% min for all sizesX-Small: 532%; Small: 539%; Medium: 542%; Large: 536%; X-Large: 529%; XX-Large: 533%
    Freedom from Holes (ASTM D5151-19)AQL 2.5Gloves Passes AQL 2.5
    Residual Powder (ASTM D6124-06)$\leq$ 2 mg/gloveX-Small: 0.21 mg/glove; Small: 0.18 mg/glove; Medium: 0.18 mg/glove; Large: 0.19 mg/glove; X-Large: 0.21 mg/glove; XX-Large: 0.20 mg/glove
    Chemotherapy Drug Permeation (ASTM D6978-05 (2019))
    Carboplatin (10mg/ml)> 240 Minutes> 240 Minutes
    Carmustine (3.3mg/ml)Not specified as an acceptance criterion value, but rather a reported breakthrough time leading to a warning. No specific "pass/fail" for this drug against a threshold is listed.15.9 Minutes
    Cisplatin (1mg/ml)> 240 Minutes> 240 Minutes
    Cyclophosphamide (20mg/ml)> 240 Minutes> 240 Minutes
    Cytarabine HCl (100mg/ml)> 240 Minutes> 240 Minutes
    Dacarbazine (10mg/ml)> 240 Minutes> 240 Minutes
    Docetaxel (10mg/ml)> 240 Minutes> 240 Minutes
    Doxorubicin HCl (2mg/ml)> 240 Minutes> 240 Minutes
    Etoposide (20mg/ml)> 240 Minutes> 240 Minutes
    Fluorouracil (50mg/ml)> 240 Minutes> 240 Minutes
    Gemcitabine (38mg/ml)> 240 Minutes> 240 Minutes
    Ifosfamide (50mg/ml)> 240 Minutes> 240 Minutes
    Irinotecan (20mg/ml)> 240 Minutes> 240 Minutes
    Mechlorethamine HCl (1mg/ml)> 240 Minutes> 240 Minutes
    Melphalan (5mg/ml)> 240 Minutes> 240 Minutes
    Methotrexate (25mg/ml)> 240 Minutes> 240 Minutes
    Mitoxantrone (2mg/ml)> 240 Minutes> 240 Minutes
    Paclitaxel (6mg/ml)> 240 Minutes> 240 Minutes
    Thiotepa (10mg/ml)Not specified as an acceptance criterion value, but rather a reported breakthrough time leading to a warning. No specific "pass/fail" for this drug against a threshold is listed.54.2 Minutes
    Biocompatibility (ISO 10993 Series)
    Primary Skin Irritation (ISO 10993-23)Under the condition of study not an irritantUnder the condition of study, not an irritant
    Dermal Sensitization (ISO 10993-10)Under the conditions of the study, not a sensitizerUnder the conditions of the study, not a sensitizer
    In Vitro Cytotoxicity (ISO 10993-5)Under the conditions of the study, non-cytotoxicUnder the conditions of the study, non-cytotoxic
    Acute Systemic Toxicity (ISO 10993-11)Under the conditions of study, the device extracts do not pose a systemic toxicity concernUnder the conditions of the study, the test item did not produce any adverse effect

    2. Sample size used for the test set and the data provenance

    The document does not explicitly state the specific sample sizes used for each test. For many of the physical and chemical property tests (e.g., dimensions, tensile strength, freedom from holes, residual powder, chemotherapy drug permeation), the relevant ASTM standards (e.g., ASTM D6319-19, ASTM D5151-19, ASTM D6124-06, ASTM D6978-05) would specify the required statistical sampling plans, but the summary document only provides the results.

    Similarly, for biocompatibility tests (ISO 10993 series), the number of animals or cell cultures used is not detailed in this summary, but the standards themselves outline the required protocols.

    The data provenance is not explicitly stated in terms of country of origin of the data or whether it was retrospective or prospective. Given that these are bench and lab tests for a premarket notification, it's highly probable that the tests were conducted prospectively by the manufacturer or a contracted testing laboratory to demonstrate compliance with the referenced standards.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    This information is not applicable and not provided since the studies performed are bench testing and biocompatibility testing against established international standards (ASTM and ISO). These types of tests do not typically involve human experts establishing a "ground truth" through interpretation, as would be the case for an AI diagnostic device. Instead, the "ground truth" is defined by the objective measurement parameters and criteria specified in the standard test methods themselves.

    4. Adjudication method for the test set

    Not applicable. As noted above, these are objective bench and lab tests against predefined specifications in standards. There is no subjective interpretation requiring an adjudication method like 2+1 or 3+1. The results are quantitative measurements or direct observations (e.g., passes/fails AQL).

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    Not applicable. This device is a medical glove, not an AI diagnostic device. Therefore, no MRMC study involving human readers or AI assistance was conducted or would be relevant.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    Not applicable. This device is a medical glove, not an AI algorithm.

    7. The type of ground truth used

    The "ground truth" for the performance evaluation of these nitrile examination gloves are the acceptance criteria defined by the relevant ASTM and ISO standards. These standards provide:

    • Specific measurable thresholds (e.g., minimum length, minimum tensile strength, maximum residual powder).
    • Defined test methods and methodologies (e.g., how to measure breakthrough time for chemotherapy drugs, how to assess irritation or sensitization).
    • Statistical sampling plans (e.g., AQL for freedom from holes).

    Compliance with these pre-defined, objective criteria from the standards constitutes the "ground truth" for the device's performance.

    8. The sample size for the training set

    Not applicable. This is a physical device (medical glove), not an AI model. Therefore, there is no "training set."

    9. How the ground truth for the training set was established

    Not applicable, as there is no training set for a physical medical device.

    Ask a Question

    Ask a specific question about this device

    Why did this record match?
    Device Name :

    Jr Medic Blue Nitrile Examination Gloves Powder Free tested for use with Chemotherapy drugs

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    JR Medic Blue Nitrile Examination Gloves Powder Free tested for use with Chemotherapy drugs is a disposable device intended for medical purpose that is worn on the examination between patient and examiner.

    Additionally, the gloves were tested for use with chemotherapy drugs in accordance with ASTM D6978-05 (2019) Standard Practice for Assessment of Medical Glove to Permeation by Chemotherapy Drugs.

    The tested chemotherapy drugs and their breakthrough detection times are as follows:

    Tested Chemotherapy Drug Name & ConcentrationMinimum Breakthrough Detection Time
    Carmustine (BCNU) (3.3 mg/ml)35.0 Minutes
    Carboplatin (10 mg/ml)>240 Minutes
    Cisplatin (1 mg/ml)>240 Minutes
    Cyclophosphamide (Cytoxan) (20 mg/ml)>240 Minutes
    Dacarbazine (10.0 mg/ml)>240 Minutes
    Doxorubicin HCl (2 mg/ml)>240 Minutes
    Etoposide (20 mg/ml)>240 Minutes
    Fluorouracil (50 mg/ml)>240 Minutes
    Ifosfamide (50 mg/ml)>240 Minutes
    Methotrexate (25 mg/ml)>240 Minutes
    Mitomycin C (0.5 mg/ml)>240 Minutes
    Mitoxantrone (2 mg/ml)>240 Minutes
    Paclitaxel (6 mg/ml)>240 Minutes
    Thiotepa (10 mg/ml)64.9 Minutes
    Vincristine Sulfate (1 mg/ml)>240 Minutes
    Device Description

    The subject device in 510(K) notification is JR Medic blue nitrile examination gloves powder free tested for use with Chemotherapy drugs.

    The subject device is a patient examination glove made from acrylonitrile-butadiene copolymer dispersion, blue color, powder free and non sterile (as per 21CFR 880.6250, class I).

    The subject device meets all the current specifications listed under the ASTM Specification D 6319 -2019, Standard Specification for Nitrile Examination Gloves for Medical Application. This device also complies with requirements for standard practice for assessment of resistance of medical gloves to permeation by chemotherapy drugs as per ASTM D6978- 05(2019)

    AI/ML Overview

    I am sorry, but the provided text does not describe a study involving an AI device or algorithm, and therefore all the requested information about acceptance criteria, study design, sample sizes, ground truth, expert involvement, and MRMC studies cannot be extracted.

    The document is a 510(k) premarket notification for "JR Medic Blue Nitrile Examination Powder Free Gloves tested for use with chemotherapy drugs." It details the non-clinical testing performed on these medical gloves to demonstrate their safety and effectiveness, specifically their resistance to permeation by chemotherapy drugs, in accordance with established ASTM (American Society for Testing and Materials) standards.

    The document focuses on the physical, chemical, and biocompatibility properties of the gloves, not on the performance of a software algorithm or AI.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1